Cargando…

Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection

In a Perspective, Klaus Pantel discusses prospects for use of cell-free DNA and circulating tumor cells in cancer detection.

Detalles Bibliográficos
Autor principal:	Pantel, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189941/ https://www.ncbi.nlm.nih.gov/pubmed/28027295 http://dx.doi.org/10.1371/journal.pmed.1002205

Ejemplares similares

Circulating tumour cells for early detection of clinically relevant cancer
por: Lawrence, Rachel, et al.
Publicado: (2023)

Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
por: Heidrich, Isabel, et al.
Publicado: (2022)

TP53 mutations on circulating cell-free DNA
por: Pantel, Klaus
Publicado: (2016)

Electrochemical Biosensors for Circulating Tumor DNA Detection
por: Wang, Ke, et al.
Publicado: (2022)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

Circulating cell-free DNA for cancer early detection
por: Gao, Qiang, et al.
Publicado: (2022)

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
por: Heidrich, Isabel, et al.
Publicado: (2021)

Biology, detection, and clinical implications of circulating tumor cells
por: Joosse, Simon A, et al.
Publicado: (2015)

Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
por: Gorges, Katharina, et al.
Publicado: (2019)

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2009)

Cell lines from circulating tumor cells
por: Pantel, Klaus, et al.
Publicado: (2015)

Evaluation of circulating tumor DNA as a biomarker for gynecological tumors
por: Liu, Kang-Sheng, et al.
Publicado: (2020)

Circulating Tumor Cells: From the Laboratory to the Cancer Clinic
por: Agashe, Ruchi, et al.
Publicado: (2020)

Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns
por: Lu, Jun-Liang, et al.
Publicado: (2016)

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
por: Jaworski, Jedrzej J., et al.
Publicado: (2020)

Brain-derived cell-free DNA
por: Southwood, Dean, et al.
Publicado: (2022)

Detection and Characterization of Circulating Tumor Cells Using Imaging Flow Cytometry—A Perspective Study
por: Muchlińska, Anna, et al.
Publicado: (2022)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Cell-free circulating tumor DNA in cancer
por: Qin, Zhen, et al.
Publicado: (2016)

Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
por: Keller, Laura, et al.
Publicado: (2020)

Circulating DNA as biomarker in breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2015)

Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
por: Uehiro, Natsue, et al.
Publicado: (2016)

Clinical relevance and biology of circulating tumor cells
por: Bednarz-Knoll, Natalia, et al.
Publicado: (2011)

Low Levels of Cell-Free Circulating miR-361-3p and miR-625* as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors
por: Roth, Carina, et al.
Publicado: (2012)

Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study
por: Sui, Jinke, et al.
Publicado: (2021)

Recent translational research: circulating tumor cells in breast cancer patients
por: Müller, Volkmar, et al.
Publicado: (2006)

BLOODPAC: Collaborating to chart a path towards blood‐based screening for early cancer detection
por: Clarke, Christina A., et al.
Publicado: (2022)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma
por: Geidel, Glenn, et al.
Publicado: (2022)

Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
por: Earl, Julie, et al.
Publicado: (2015)

Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer
por: Yu, Pengjie, et al.
Publicado: (2022)

Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives
por: Müller, Volkmar, et al.
Publicado: (2004)

Circulating cell-free DNA content as blood based biomarker in endometrial cancer
por: Cicchillitti, Lucia, et al.
Publicado: (2017)

Applications of cell-free circulating tumor DNA detection in EGFR mutant lung cancer
por: Bulbul, Ajaz, et al.
Publicado: (2020)

Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood
por: Gyanchandani, Rekha, et al.
Publicado: (2018)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Intraoperative detection of circulating tumor cells in pulmonary venous blood during metastasectomy for colorectal lung metastases
por: Le, Uyen-Thao, et al.
Publicado: (2018)

Non-blood circulating tumor DNA detection in cancer
por: Peng, Muyun, et al.
Publicado: (2017)

Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation
por: Pantel, Klaus, et al.
Publicado: (2022)

Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
por: Fernandez-Cuesta, Lynnette, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8l2lsq3o0p5sppsspomk60rdjm